GeneDx Holdings Corp.
WGS
$85.74
-$5.87-6.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.96% | 21.67% | |||
| Total Other Revenue | -6.09% | 365.44% | |||
| Total Revenue | -8.91% | 24.41% | |||
| Cost of Revenue | -2.70% | 1.36% | |||
| Gross Profit | -11.67% | 38.40% | |||
| SG&A Expenses | 16.03% | 0.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | 1.42% | |||
| Total Operating Expenses | 7.67% | 0.58% | |||
| Operating Income | -143.33% | 235.12% | |||
| Income Before Tax | -212.34% | 164.77% | |||
| Income Tax Expenses | 1,962.50% | 48.94% | |||
| Earnings from Continuing Operations | -220.06% | 165.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -220.06% | 165.42% | |||
| EBIT | -143.33% | 235.12% | |||
| EBITDA | -92.57% | 921.79% | |||
| EPS Basic | -218.55% | 163.79% | |||
| Normalized Basic EPS | -130.15% | 332.33% | |||
| EPS Diluted | -218.55% | 163.79% | |||
| Normalized Diluted EPS | -130.15% | 332.33% | |||
| Average Basic Shares Outstanding | 1.31% | 2.54% | |||
| Average Diluted Shares Outstanding | 1.31% | 2.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||